Xentria, Inc. logo

Xentria, Inc.

10 Live Marks
12 on record
Corp.
First Filed:Apr 29, 2020Latest Filed:Feb 28, 2025Address:8700 W Bryn Mawr Ave, Chicago, IL 60631, US

Portfolio Overview

Top Classes

Class 42
Software, IT Services & Scientific Research
10(83%)
Class 36
Insurance, Financial Services & Real Estate
6(50%)
Class 35
Advertising, Business Services & Retail
6(50%)

TTAB Proceedings

No oppositions or cancellations
1 extension of time to oppose

Top Firms

McDonnell Boehnen Hulbert & ...(Feb 2025)
12

Trademark Portfolio

12 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
XENTRIA
XENTRIA
Service Mark
Combined
REGISTERED
Owner:
Serial:99061771
Filed:Feb 28, 2025
Classes:42, 44
Registration:7960762
Registered:Sep 23, 2025
Description: Providing medical information; Providing health information; Research and development in the field of biologics, biosimilars, and pharmaceuticals; Providing information about medical research in the field of biologics, biosimilars, and pharmaceuticals
XENTRIA
XENTRIA
Service Mark
Combined
REGISTERED
Owner:
Serial:99061795
Filed:Feb 28, 2025
Classes:42, 44
Registration:8028717
Registered:Nov 18, 2025
Description: Providing medical information; Providing health information; Research and development in the field of biologics, biosimilars, and pharmaceuticals; Providing information about medical research in the field of biologics, biosimilars, and pharmaceuticals
XENTRIA
XENTRIA
Service Mark
Combined
REGISTERED
Owner:
Serial:99061838
Filed:Feb 28, 2025
Classes:42, 44
Registration:8442045
Registered:Sep 15, 2026
Description: Providing medical information; Providing health information; Research and development in the field of biologics, biosimilars, and pharmaceuticals; Providing information about medical research in the field of biologics, biosimilars, and pharmaceuticals
X
X
Service Mark
Stylized
PENDING
Owner:
Serial:99007677
Filed:Jan 17, 2025
Classes:35, 36, 42
Description: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
X
X
Service Mark
Stylized
ABANDONED
Owner:
Serial:99007707
Filed:Jan 17, 2025
Classes:35, 36, 42
Description: Class 35: Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics
Class 36: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics
Class 42: Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XENTRIA
XENTRIA
Trademark
Word
PENDING
Owner:
Serial:99007883
Filed:Jan 17, 2025
Classes:5
Description: Biologic, biosimilar, and pharmaceutical preparations for the treatment of bone disease; Biologic, biosimilar, and pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; Biologic, biosimilar, and pharmaceutical preparations for the treatment of diabetes; Biologic, biosimilar, and pharmaceutical preparations for treatment and prevention of autoimmune diseases and autoimmune disorders; Biologic, biosimilar, and pharmaceutical oncology preparations for the treatment of cancer; Anti-inflammatories; Biologic, biosimilar, and pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Biologic, biosimilar, and pharmaceutical preparations for use in dermatology; Biologic, biosimilar, and pharmaceutical preparations for use in rheumatology; Biologic, biosimilar, and pharmaceutical preparations, namely, anti-tumor necrosis factor alpha (TNF-a) receptor monoclonal antibody for the treatment and prevention of disease influenced by TNF-a production; Biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment and prevention of immune and inflammatory diseases and disorders
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
ABANDONED
Owner:
Serial:99007567
Filed:Jan 17, 2025
Classes:35, 36, 42
Description: Class 35: Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics
Class 36: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics
Class 42: Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
PENDING
Owner:
Serial:99007760
Filed:Jan 17, 2025
Classes:35, 36, 42
Description: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
PENDING
Owner:
Serial:99007634
Filed:Jan 17, 2025
Classes:35, 36, 42
Description: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
PENDING
Owner:
Serial:99007812
Filed:Jan 17, 2025
Classes:35, 36, 42
Description: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
TRINSERRA
TRINSERRA
Trademark
Word
ABANDONED
Owner:
Serial:88893369
Filed:Apr 29, 2020
Classes:5
XENTRIA
XENTRIA
Trademark
Word
REGISTERED
Owner:
Serial:88893382
Filed:Apr 29, 2020
Classes:5, 42, 44
Registration:7746734
Registered:Apr 1, 2025
Description: Providing medical information; providing health information; research and development of biologics, biosimilars, and pharmaceuticals; providing information in the field of scientific and medical research related to biologics, biosimilars, and pharmaceuticals